D. Western Therapeutics Institute (TSE:4576) Total Inventories: 円86.92 Mil (As of Dec. 2025)

What is D. Western Therapeutics Institute Total Inventories?

D. Western Therapeutics Institute TSE:4576 51 Total Inventories is 円86.92 Mil as of Dec. 2025. GuruFocus rates TSE:4576 with a GF Score™ of 51/100 and a GF Value™ of 円64.35 (Fairly Valued). The stock has 3 warning signs investors should review.

D. Western Therapeutics Institute's total inventories for the quarter that ended in Dec. 2025 was 円86.92 Mil. D. Western Therapeutics Institute's average total inventories from the quarter that ended in Jun. 2025 to the quarter that ended in Dec. 2025 was 円93.20 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. D. Western Therapeutics Institute's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was 円20.09.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. D. Western Therapeutics Institute's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

D. Western Therapeutics Institute (TSE:4576) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

D. Western Therapeutics Institute's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is

	Net-Net Working Capital Per Share (Q: Dec. 2025 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1709.79	+	0.75 * 94.502	+	0.5 * 86.921	-	734.012
-	0	-	0)	/	54.251
=	20.09

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

D. Western Therapeutics Institute's Days Inventory for the three months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	93.196	/	0	*	365 / 4
	=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

D. Western Therapeutics Institute's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2025 )	/	Average Total Inventories (Q: Dec. 2025 )
	=	0	/	93.196
	=	0.00

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

D. Western Therapeutics Institute's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	93.196	/	0
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

D. Western Therapeutics Institute Total Inventories Related Terms

D. Western Therapeutics Institute Total Inventories Historical Data

* Premium members only.

The historical data trend for D. Western Therapeutics Institute's Total Inventories can be seen below:

D. Western Therapeutics Institute Total Inventories Chart

D. Western Therapeutics Institute Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Inventories

Get a 7-Day Free Trial

88.40

79.21

87.86

101.96

86.92

D. Western Therapeutics Institute Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25	Jun25	Dec25	Mar26
Total Inventories	Get a 7-Day Free Trial															101.96	100.63	99.47	86.92	131.71

51GF Score

D. Western Therapeutics Institute Inc TSE:4576

Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

D. Western Therapeutics Institute Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →

What does a Total Inventories of 円86.92 Mil mean?

D. Western Therapeutics Institute (TSE:4576) has a Total Inventories of 円86.92 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for D. Western Therapeutics Institute and its competitors.

Is D. Western Therapeutics Institute's Total Inventories too high?

D. Western Therapeutics Institute's current Total Inventories is 円86.92 Mil. Overall, D. Western Therapeutics Institute has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does D. Western Therapeutics Institute's Total Inventories compare to VRTX and REGN?

D. Western Therapeutics Institute's Total Inventories of 円86.92 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Inventories for a Biotechnology company?

A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Inventories mean?

A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for D. Western Therapeutics Institute and its competitors. D. Western Therapeutics Institute's current Total Inventories is 円86.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is D. Western Therapeutics Institute stock overvalued right now?

Based on GuruFocus' analysis, D. Western Therapeutics Institute (TSE:4576) is currently considered Fairly Valued. The stock's GF Value™ is 円64.35, compared to a current price of 円69.00 — trading 7.2% above its estimated fair value. The current Total Inventories is 円86.92 Mil. D. Western Therapeutics Institute's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Inventories calculated?

Total Inventories is calculated from a company's financial statements. For D. Western Therapeutics Institute (TSE:4576), the current Total Inventories is 円86.92 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D. Western Therapeutics Institute (TSE:4576) Overvalued in 2026?

Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued. The current stock price of 円69.00 is trading 7.2% above its estimated GF Value™ of 円64.35. GuruFocus considers D. Western Therapeutics Institute to be Fairly Valued.

Key valuation signals for TSE:4576:

Total Inventories: 円86.92 Mil
GF Value™: 円64.35 vs. price of 円69.00 (7.2% above fair value)
GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the TSE:4576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

D. Western Therapeutics Institute Business Description

Industry Healthcare Biotechnology

Comparable Companies TSE:2342 TSE:4591 TSE:2183 TSE:177A TSE:206A TSE:4884 TSE:4893 TSE:130A TSE:4881 TSE:4891 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 6DW:Germany

Address 7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003

Website http://www.dwti.co.jp

D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.

51GF Score

Get the complete analysis for TSE:4576

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円69.00

Price

円64.35

GF Value

View TSE:4576 Analysis

See Total Inventories data for all stocks →